A pro-life doctor’s group is challenging the FDA’s approval of mifepristone and subsequent deregulation of the drug. Oral arguments in the case were heard March 26, ahead of an expected June ruling.
A pro-life doctor’s group is challenging the FDA’s approval of mifepristone and subsequent deregulation of the drug. Oral arguments in the case were heard March 26, ahead of an expected June ruling.
Ali ste se že posvetili Jezusovemu in Marijinemu Srcu
